THE LATEST FROM RAKOVINA
Discovery in motion.
Rakovina Therapeutics Secures Exclusivity on Optimized kt-5000 Lead Profile from Variational AI
DOWNLOAD Agreement provides Rakovina exclusive access to its optimized kt-5000 target profile and extends AI-powered lead optimization through year-end at no additional cost VANCOUVER, British Columbia, October 14, 2026 (GLOBE NEWSWIRE) – Rakovina Therapeutics Inc....
Rakovina Therapeutics Partners with Boston-based Celvion Therapeutics to Leverage AI and Real-World Clinical Data for Precision Cancer Drug Development
DOWNLOAD Collaboration to identify optimal combination therapies, predictive biomarkers and patient populations for Rakovina’s ATR inhibitor program VANCOUVER, British Columbia, October 1, 2026 (GLOBE NEWSWIRE) – Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0)...
Rakovina Therapeutics Announces Appointment of New Scientific Advisory Board Member
DOWNLOAD Yale physician-scientist and biotech entrepreneur Dr. Ranjit Bindra brings deep expertise in DNA repair, synthetic lethality and brain tumor therapeutics VANCOUVER, British Columbia, September 17, 2026 (GLOBE NEWSWIRE) – Rakovina Therapeutics Inc. (TSX-V:...
Rakovina Therapeutics Announces Appointment of Professor Petra Hamerlik to its Board of Directors
DOWNLOAD Chair of Translational Neuro-Oncology at the University of Manchester, previously a member of the Company's Scientific Advisory Board, elected at the 2026 Annual General Meeting VANCOUVER, British Columbia, September 10, 2026 (GLOBE NEWSWIRE) -- Rakovina...
Rakovina Therapeutics Announces Final Closing of Upsized Non-Brokered Private Placement
DOWNLOAD Financing completed at the full upsized amount following strong investor demand VANCOUVER, British Columbia, August 31, 2026 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing innovative cancer...
Rakovina Therapeutics Announces Results from 2026 Annual General Meeting
VANCOUVER, British Columbia, August 19, 2026 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through AI-powered drug discovery, is pleased to announce the results of voting at...
Rakovina Therapeutics Announces Closing of First Tranche, Upsize and Extension of Non-Brokered Private Placement
Expanded financing broadens Rakovina’s strategic investor base and reinforces confidence in its AI-powered oncology platform DOWNLOAD VANCOUVER, British Columbia, August 12, 2026 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0), a...
Rakovina Therapeutics Announces Closing of First Tranche, Upsize and Extension of Non-Brokered Private Placement
Rakovina Therapeutics Announces Closing of First Tranche, Upsize and Extension of Non-Brokered Private Placement DOWNLOAD VANCOUVER, British Columbia, August 12, 2026 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company...
Rakovina Therapeutics Announces $1.5 Million Private Placement
DOWNLOAD VANCOUVER, British Columbia, July 15, 2026 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV)( FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered drug discovery, today announces...
Rakovina Therapeutics Announces $1.5 Million Private Placement
DOWNLOAD VANCOUVER, British Columbia, July 15, 2026 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV)( FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered drug discovery, today announces a...
Rakovina Therapeutics Announces Q1 2026 Financial Results and Provides Corporate Update
All dollar amounts reflected in Canadian dollars unless otherwise stated. VANCOUVER, British Columbia, June 1, 2026 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through...
Rakovina Therapeutics Announces Q1 2026 Financial Results and Provides Corporate Update
DOWNLOAD All dollar amounts reflected in Canadian dollars unless otherwise stated. VANCOUVER, British Columbia, June 1, 2026 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies...
